Anticoagulant therapy after venous thromboembolism and 10-year mortality

International Journal of Cardiology

Volumn 208, Issue , 2016, Pages 72-78

  Larsen, Torben Bjerregaard ^a,b   Lip, Gregory Y H ^b,c   Gorst Rasmussen, Anders ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Anticoagulation; Embolism; Mortality; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DANISH CITIZEN; DEEP VEIN THROMBOSIS; DENMARK; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RATE; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL RATE; VENOUS THROMBOEMBOLISM; EPIDEMIOLOGY; MIDDLE AGED; PULMONARY EMBOLISM; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; TRENDS; VENOUS THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PULMONARY EMBOLISM; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84959293748     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.01.190     Document Type: Article

References (19)

1. A.T. Cohen, G. Agnelli, F.A. Anderson, J.I. Arcelus, D. Bergqvist, J.G. Brecht, and et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality Thromb. Haemost. 98 2007 756 764
2. S.Z. Goldhaber, and H. Bounameaux Pulmonary Embolism and Deep Vein Thrombosis Lancet 379 2012 Elsevier Ltd 1835 1846
3. R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, A.S. Gallus, and et al. Oral rivaroxaban for symptomatic venous thromboembolism N. Engl. J. Med. 363 2010 2499 2510
4. G. Agnelli, H.R. Buller, A. Cohen, M. Curto, A.S. Gallus, M. Johnson, and et al. Oral apixaban for the treatment of acute venous thromboembolism N. Engl. J. Med. 369 2013 799 808
5. H.R. Büller, H. Décousus, M.A. Grosso, M. Mercuri, S. Middeldorp, M.H. Prins, and et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism N. Engl. J. Med. 369 2013 1406 1415
6. H.R. Büller, M.H. Prins, A.W.A. Lensin, H. Decousus, B.F. Jacobson, E. Minar, and et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N. Engl. J. Med. 366 2012 1287 1297
7. K.K. Søgaard, M. Schmidt, L. Pedersen, E. Horváth-Puhó, and H.T. Sørensen 30-year mortality after venous thromboembolism: a population-based cohort study Circulation 130 2014 829 836
8. H.R. Büller, G. Agnelli, R.D. Hull, T.M. Hyers, M.H. Prins, and G.E. Raskob Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 401S 428S
9. C. Kearon, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 454S 545S
10. Guidelines on diagnosis and management of acute pulmonary embolism Task Force on Pulmonary Embolism, European Society of Cardiology Eur. Heart J. 21 2000 1301 1336
11. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galiè, P. Pruszczyk, and et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J. 29 2008 2276 2315
12. S. Konstantinides, A. Torbicki, G. Agnelli, N. Danchin, D. Fitzmaurice, N. Galie, and et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)∗Endorsed by the European Respiratory Society (ERS) Eur Heart J 2014 (2014)
13. J. Menzin, R. Preblick, M. Friedman, J. Menzin, M. Frean, and K.W. Jacqueline Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data Hosp. Pract. 42 1995 59 74 (2014)
14. M. Schmidt, L. Pedersen, and H.T. Sørensen The danish civil registration system as a tool in epidemiology Eur. J. Epidemiol. 29 2014 541 549
15. E. Lynge, J.L. Sandegaard, and M. Rebolj The Danish National Patient Register Scand. J. Public Health 39 2011 30 33
16. H.W. Kildemoes, H.T. Sørensen, and J. Hallas The Danish National Prescription Registry Scand. J. Public Health 39 2011 38 41
17. S.K. Thygesen, C.F. Christiansen, S. Christensen, T.L. Lash, and H.T. Sørensen The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients BMC Med. Res. Methodol. 11 2011 83
18. J.R. Anderson, K.C. Cain, and R.D. Gelber Analysis of survival by tumor response J. Clin. Oncol. 1 1983 710 719
19. M.T. Severinsen, S.R. Kristensen, K. Overvad, C. Dethlefsen, A. Tjønneland, and S.P. Johnsen Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution J. Clin. Epidemiol. 63 2010 223 228